Contralateral circling behaviour induced by intranigral injection of taurine in rats. 1980

S Kaakkola, and I Kääriäinen

A study was made of the effect of unilateral injection of taurine into the substantia nigra on the behaviour of rats. Taurine (10-200 micrograms) induced a dose-dependent contralateral circling behaviour. The maximum intensity of circling after doses of 100-200 micrograms of taurine was reached within 10 min. and the circling lasted for about 4-5 hrs. There was neither ipsilateral circling nor stereotyped behaviour. Intranigral injection of isethionic acid, a metabolite of taurine, induced weak ipsilateral circling of short duration. Pretreatment with bicuculline (3 mg/kg intraperitoneally) or strychnine (0.25 mg/kg intraperitoneally) significantly inhibited the taurine-induced circling. A dose of 1 mg/kg but not of 0.5 mg/kg of haloperidol (subcutaneously) significantly decreased the intensity of the taurine-induced circling. Pretreatment with atropine (10 mg/kg intraperitoneally) had no significant effect on the circling behaviour. Besides the dopaminergic nigrostriatal pathway, the nondopaminergic nigral output pathways also seem to be involved in the taurine-induced circling behaviour. The results show that taurine may play some role in the function of the substantia nigra.

UI MeSH Term Description Entries
D007513 Isethionic Acid A colorless, syrupy, strongly acidic liquid that can form detergents with oleic acid. Hydroxyethylsulfonic Acid,Isethionic Acid Monoammonium Salt,Isethionic Acid Monopotassium Salt,Isethionic Acid Monosodium Salt,Sodium Isethionate,Acid, Hydroxyethylsulfonic,Acid, Isethionic,Isethionate, Sodium
D008845 Microinjections The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes. Microinjection
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001285 Atropine An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine. AtroPen,Atropin Augenöl,Atropine Sulfate,Atropine Sulfate Anhydrous,Atropinol,Anhydrous, Atropine Sulfate,Augenöl, Atropin,Sulfate Anhydrous, Atropine,Sulfate, Atropine
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors

Related Publications

S Kaakkola, and I Kääriäinen
March 1980, Archives internationales de pharmacodynamie et de therapie,
S Kaakkola, and I Kääriäinen
November 1980, Acta pharmacologica et toxicologica,
S Kaakkola, and I Kääriäinen
August 1995, European journal of pharmacology,
S Kaakkola, and I Kääriäinen
November 1977, The Journal of pharmacology and experimental therapeutics,
S Kaakkola, and I Kääriäinen
June 1977, European journal of pharmacology,
S Kaakkola, and I Kääriäinen
January 1989, Journal de toxicologie clinique et experimentale,
S Kaakkola, and I Kääriäinen
February 1981, European journal of pharmacology,
Copied contents to your clipboard!